- Discussing protectionism, consolidation, drug pricing and regulatory issues:
- What does it all mean for the CMO/CDMO industry?
- Assessing the decision to bring manufacturing in-house and/or to move their production facilities to the U.S.
- Examining the impacts of regulations, such as FDARA, PDUFA, GDUFA, BsUFA and MDUFA